MSF Access Campaign
Migrating while managing diabetes: why access to insulin in pens must be available to everyone
MSF calls for equitable access to TB drugs and diagnostics in first-ever plenary session on access at the TB Union Conference
MSF and global TB activists take stage at annual TB conference
MSF calls for urgent action as governments and donors are failing children with TB
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Secrets Cost Lives: Transparency and access to medical products
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
